Parents who have not already done so need to make time for newborn follow-up of the discharge. According to the American Academy of Pediatrics (AAP), when should a breastfeeding infant first need to be seen for a follow-up examination?

A. Reinforce postpartum and newborn care discharge teaching: While reinforcing teaching about postpartum care is important, the priority action is to assess the client’s emotional and mental well-being, as there are signs of possible depression or more severe emotional distress.

B. Assist the family to identify prior use of positive coping skills in family crises: While assessing coping skills can be beneficial in supporting the client, the immediate concern is the client's mental state and potential risk to herself or her newborn, which requires prompt attention.

C. Ask the client if she has considered harming her newborn: This is the priority action. The client’s report of feeling "down," sad, having no energy, and wanting to cry may indicate postpartum depression or more severe conditions like postpartum psychosis, which could pose a risk to both the client and her newborn. Asking directly about harm to the newborn is crucial for ensuring safety and guiding the next steps for care.

D. Anticipate a prescription by the provider for an antidepressant: While antidepressants may be prescribed for postpartum depression, the priority is to assess the client's safety first and intervene as needed before proceeding with treatment options. The provider will determine the appropriate treatment based on a comprehensive evaluation.

A. It prevents the formation of Rh antibodies in newborns who are Rh positive: Rh immunoglobulin is administered to the mother, not the newborn. It does not prevent antibody formation in the infant; instead, it prevents maternal sensitization that can harm future pregnancies.

B. It prevents the formation of Rh antibodies in mothers who are Rh negative: Rh(D) immunoglobulin works by suppressing the maternal immune response to fetal Rh-positive red blood cells. This prevents the formation of maternal anti-D antibodies, which could attack fetal red cells in future pregnancies.

C. It destroys Rh antibodies in mothers who are Rh negative: Rh immunoglobulin does not destroy antibodies already formed. If maternal sensitization has occurred and anti-D antibodies are already present, RhIg is no longer effective or indicated.

D. It destroys Rh antibodies in newborns who are Rh positive: RhIg has no role in treating or affecting the newborn’s immune system. It acts only in the Rh-negative mother to prevent alloimmunization after potential fetal-maternal blood mixing.